# Fresenius Medical Care AG: Form 20-F for the period ended Dec 31, 2012

- Company: [Fresenius Medical Care AG](/companies/fms.md) (CIK 1333141)
- Form: 20-F
- Filed: 2013-02-26
- Accepted by EDGAR: Feb 26, 2013, 14:32 ET
- Period: 2012-12-31
- Accession: 0001047469-13-001694
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1333141/000104746913001694/a2212977z20-f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1333141/000104746913001694/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 12 months, 2012-01-01 to 2012-12-31 | $9.20bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2012-01-01 to 2012-12-31 | $4.60bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2012-01-01 to 2012-12-31 | $111.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2012-01-01 to 2012-12-31 | $2.22bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2012-01-01 to 2012-12-31 | $2.22bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2012-01-01 to 2012-12-31 | $470.5m | us-gaap:InterestExpense |
| Income tax | 12 months, 2012-01-01 to 2012-12-31 | $605.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2012-01-01 to 2012-12-31 | $1.19bn | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 12 months, 2012-01-01 to 2012-12-31 | 302,900,716 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2012-01-01 to 2012-12-31 | $2.04bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2012-01-01 to 2012-12-31 | $675.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2012-01-01 to 2012-12-31 | $271.7m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | at 2012-12-31 | $688.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2012-12-31 | $6.13bn | us-gaap:AssetsCurrent |
| Total assets | at 2012-12-31 | $22.33bn | us-gaap:Assets |
| Current liabilities | at 2012-12-31 | $3.17bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2012-12-31 | $12.60bn | us-gaap:Liabilities |
| Long-term debt | at 2012-12-31 | $7.84bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2012-12-31 | $121.8m | us-gaap:DebtCurrent |
| Short-term borrowings | at 2012-12-31 | $117.8m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2012-12-31 | $8.94bn | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1333141/000104746913001694/a2212977z20-f.htm

Filed Feb 26, 2013.
Source: SEC EDGAR, the filing index for accession 0001047469-13-001694. Last ingested by Listed: Nov 14, 2026, 17:40 ET. No prices; not investment advice.
